← All trials
NCT06154083
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 12, 2023
- Primary completion
- Dec 15, 2025
- Completion date
- May 15, 2026
- First posted
- Dec 1, 2023
- Last posted
- Dec 13, 2023
- Enrollment
- 110
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fundación Santiago Dexeus FontLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.